- Find
- Manage
- Resources
Is Tamazepam Fda Approved For Treatment Of Insomnia?
The U.S. Food and Drug Administration has approved Edluar for the short-term treatment of insomnia. The drug, which is approved in 5 mg and 10 mg sublingual tablets, is expected to be available in the second half of 2009.
Read moreMore information on "Is Tamazepam Fda Approved For Treatment Of Insomnia?"
From Our Experts
Insomnia Treatment Options
To continue where we left in our discussion of insomnia, we should start reviewing the treatment options. First, we should address the... Read more »
FDA Approves Cymbalta for Chronic Musculoskeletal Pain
The FDA has now approved Cymbalta (duloxetine) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic... Read more »
New Drug Ampyra Approved by FDA for Multiple Sclerosis Patients
Late Friday afternoon, January 22, 2010, the Food and Drug Administration (FDA) announced that they approved AMPYRA™ (dalfampridine,... Read more »
FDA Approves Risperdal for the Treatment of Schizophrenia and Bipolar...
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event.... Read more »
Zelrix Submitted to FDA for Approval for Migraine Treatment
NuPathe, Inc., a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of... Read more »
From Our Sources
FDA Approves Insomnia Med Silenor
The U.S. Food and Drug Administration has approved Silenor for the treatment of insomnia. The new medication, from drugmaker Somaxon, has been... Read more »
FDA approves new treatment for bipolar I disorder
The U.S. Food and Drug Administration has approved Risperdal Consta for the treatment of bipolar I disorder. The drug was approved both as a... Read more »
FDA Approves Nexium For Short-Term Treatment of GERD in Adoles...
The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of... Read more »
Zolpimist approved for insomnia
The U.S. Food and Drug Administration has approved an oral spray for the treatment of insomnia. Zolpimist contains the active ingredient found in the... Read more »
FDA approves generic Prilosec
The Indian drug company Dr Reddy's Laboratories Ltd says that the U.S. Food and Drug Administration has approved a generic, over-the-counter version... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
